In SS mouse models, FGFR knockout or inhibition with BGJ398 suppressed tumor growth and downstream ERK signaling, leading to reduced expression of ETV4/5, transcription factors essential for SS progression [54]. This evidence concerns the gene ETV4 and synovial sarcoma.